Prostacyclin and prostaglandin E induce relaxation in tracheal smooth muscle and in blood vessels. In addition, prostacyclin has a powerful anticoagulant effect. Although its half life is about five minutes and is metabolized by 15-hydroxy prostaglandin dehydrogenase or in a non-enzymatic process, 6-keto prostaglandin F
1α (6-keto PGF
1α) is a stable metabolite of prostacyclin, and its concentration is higher than that of prostacyclin in circulating blood. The effects of 6-keto PGF
1α on the action of various bronchoconstrictor and bronchodilator agents were examined in guinea pig tracheal strips.
Male Hartley strain guinea pigs, weighing 150-200g, were sacrificed. Their tracheal strips were suspended in bioassay glass chambers and superfused with Krebs-Henseleit solution, PH 7.4, at 37°C saturated with oxygen and carbon dioxide (95/5, v/v). Contraction of tissues was detected by an isotonic transducer and displayed on a polyrecorder and the grade of contraction was expressed as the contraction index that is the area (cm
2) enclosed by the response curve and the base line measured with a planimeter. Upward deflection from the base line, i. e. contraction, is shown with a plus sign and downward deflection, i. e, relaxation, is shown with a minus sign.
1) The relaxation responses of 6-keto PGF
1α were weaker than that of isoproterenol (about 1/100) with continuous infusion of neostigmine bromide.
2) Serotonin-, prostaglandin F
2α-, acetylcholine-, histamine- and bradykinin-induced contractile responses were markedly attenuated with continuous infusion of low doses of 6-keto PGF
1α.
3) Isoproterenol-, prostaglandin E
2- and salbutamol-induced relaxation responses were potentiated with continuous infusion of low doses of 6-keto PGF
1α.
These results suggest that 6-keto PGF
1α, a stable metabolite of prostacyclin, has not only a bronchodilating effect by itself, but also has an attenuating effect on the action of bronchoconstrictors and a potentiating effect on the action of bronchodilators.
抄録全体を表示